Effect of Pioglitazone on Cardiovascular Outcome on Higashi-Saitama Trial in Patients With Type 2 Diabetes

This study has been completed.
Information provided by:
Dokkyo Medical University
ClinicalTrials.gov Identifier:
First received: January 5, 2007
Last updated: NA
Last verified: January 2007
History: No changes posted
We want to investigate the effects of pioglitazone on cardiovascular events in Japanese patients with type 2 diabetes.

Condition Intervention Phase
Type 2 Diabetes
Diabetic Nephropathy
Drug: pioglitazone
Phase 4

Study Type: Observational
Study Design: Observational Model: Defined Population
Time Perspective: Longitudinal

Resource links provided by NLM:

Further study details as provided by Dokkyo Medical University:

Estimated Enrollment: 1000
Study Start Date: March 2004
Estimated Study Completion Date: July 2008
Detailed Description:

Primary composite endpoints:

Cardiovascular death Non-fatal myocardial infarction and angina Non-fatal stroke Renal failure (hemodialysis/doubling of serum creatinine)

Secondary endpoints:

urinary albumin excretion diabetic retinopathy hyperlipidemia hypertension gout


Ages Eligible for Study:   20 Years to 70 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • type 2 diabetes HbA1c: more than 7% and less than 9%

Exclusion Criteria:

  • insulin treatment
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00419484

Dokkyo Medical University, Koshigaya Hospital
Koshigaya, Saitama, Japan, 343-8555
Sponsors and Collaborators
Dokkyo Medical University
Principal Investigator: Yoshimasa Aso, MD Dokkyo Medical University, Koshigaya Hospital
  More Information

ClinicalTrials.gov Identifier: NCT00419484     History of Changes
Other Study ID Numbers: 0309 
Study First Received: January 5, 2007
Last Updated: January 5, 2007
Health Authority: Japan: Institutional Review Board

Additional relevant MeSH terms:
Diabetes Mellitus, Type 2
Diabetic Nephropathies
Diabetes Complications
Diabetes Mellitus
Endocrine System Diseases
Glucose Metabolism Disorders
Kidney Diseases
Lipid Metabolism Disorders
Metabolic Diseases
Urologic Diseases
Hypoglycemic Agents
Pharmacologic Actions
Physiological Effects of Drugs

ClinicalTrials.gov processed this record on May 02, 2016